All News #Library
Others
Basking Biosciences Announces Close of $55 Million Financing
01 Feb 2024 //
BUSINESSWIRE
Basking Biosciences Presents Novel Reversible RNA-aptamer Thrombolytic
09 May 2023 //
BUSINESSWIRE
Basking Presents Positive Results for First Reversible Thrombolytic Agent
09 Feb 2023 //
BUSINESSWIRE
Basking to Present Trial Results on First Reversible Thrombolytic Agent
31 Jan 2023 //
BUSINESSWIRE

Market Place
Sourcing Support